financetom
Business
financetom
/
Business
/
Apple iPhone Demand Softer Year Over Year, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Apple iPhone Demand Softer Year Over Year, UBS Says
Sep 22, 2024 2:05 PM

12:44 PM EDT, 09/18/2024 (MT Newswires) -- Apple ( AAPL ) is experiencing softer year-over-year demand for its latest iPhone in the days following pre-order kick-off, particularly among the high-end variants, UBS Securities said in a note emailed Wednesday.

Average wait time for the iPhone 16 Pro Max models is roughly two weeks shorter across the US, China, Germany, Great Britain, France and Japan, according to data from UBS. For the Pro model, wait times are on average eight days shorter than last year's generation.

Wait times in the US for the Pro Max version are about 26 days compared with 40 days last year, even as Apple's ( AAPL ) new artificial intelligence technology is set to release on the lineup later this year, according to UBS analysts David Vogt and Andrew Spinola. In China, where macroeconomic and competitive forces are at play, wait times are roughly half of 2023 levels.

"We believe (year over year) comparisons are more meaningful in determining underlying demand, where wait times for the iPhone 16 lineup have been uninspiring since preorders began last Friday," they said.

The brokerage reiterated a neutral rating and a $236 price target on the stock. Its fiscal fourth-quarter earnings per share target of $1.58 is below the consensus' $1.60 view while its fiscal 2024 EPS estimate is a penny below the Street's $6.69 projection. Shares of Apple ( AAPL ) were up 1.8% in midday trade.

UBS estimates iPhone 16 builds in the second half of 2024 will be up 10% year over year at 86 million units compared with 78 million iPhone 15 units the year earlier. However, weaker initial wait-time data put downside risk on the numbers, Vogt and Spinola said.

With the iPhone Pro and Pro Max making up about 65% of iPhone builds in the second half of the year, the weaker luxury demand could limit average selling price growth, according to the research report.

For the base and Plus variants, wait times are virtually in line with last year, according to UBS. The brokerage estimates that builds of the base and Plus variants account for 35% of initial build rates.

Price: 220.22, Change: +3.43, Percent Change: +1.58

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
SJW Group's San Jose Water Unit Agrees to Settle General Rates Case With California Regulators
SJW Group's San Jose Water Unit Agrees to Settle General Rates Case With California Regulators
Aug 20, 2024
09:41 AM EDT, 08/20/2024 (MT Newswires) -- SJW Group's ( SJW ) unit, San Jose Water, said Tuesday that it has reached a settlement deal with California's Public Advocates Office over its alleged inclusion of chemical and waste disposal costs in the company's full cost balancing account, and for allegedly adjusting its service charge calculation. San Jose Water said the...
Sidus Space Secures $2 Million Craig Technologies Contract for US Navy Project
Sidus Space Secures $2 Million Craig Technologies Contract for US Navy Project
Aug 20, 2024
09:32 AM EDT, 08/20/2024 (MT Newswires) -- Sidus Space ( SIDU ) said Tuesday it secured a $2 million contract from Craig Technologies to manufacture two Fleet Interactive Display Equipment panels for Bechtel Plant Machinery, supporting a US Navy program. Under the agreement, Sidus Space ( SIDU ) will use its facilities and team to manufacture, assemble, test and deliver...
Amgen Says Plaque Psoriasis Drug for Pediatric Use Available in US
Amgen Says Plaque Psoriasis Drug for Pediatric Use Available in US
Aug 20, 2024
09:44 AM EDT, 08/20/2024 (MT Newswires) -- Amgen ( AMGN ) said Tuesday that Otezla is now available in the US for the treatment of moderate to severe plaque psoriasis in patients aged six to 17. The company said the US Food and Drug Administration has not approved any other oral medications for the treatment of the disease in this...
Scienjoy Regains Compliance With Nasdaq Minimum Share Price Requirement
Scienjoy Regains Compliance With Nasdaq Minimum Share Price Requirement
Aug 20, 2024
09:18 AM EDT, 08/20/2024 (MT Newswires) -- Scienjoy Holding Corp ( SJ ) Tuesday said it has received a written notification from the Nasdaq stock market telling the Chinese interactive entertainment company it has regained compliance with the $1 minimum bid share price required to maintain its listing on the Nasdaq Capital Market. According to the notification letter, Scienjoy (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved